Navigation Links
Nanoscale gene 'ignition switch' may help spot and treat cancer
Date:12/15/2010

the radioactive labels and normal ones that were not.

"This type of imaging technique has the potential to add to existing tools with more specificity in identifying the problem," says Pomper.

Pomper says that the technique could likely be used in any cancer, and the nanoparticle and HSV1tk gene used in the current study have been tested previously in clinical studies unrelated to Pomper's work.

In addition to diagnostic and monitoring tools, the technique could be designed to deliver therapies to the heart of cancer cells. One approach, he says is to use radioactive isotopes to make cancer cells radioactive from the inside, instead of delivering radiation to the patient externally.

Still, Pomper says, such a technique would be limited to identifying tumors that are two millimeters or larger, amounting to millions of cells, because current imaging devices cannot detect anything smaller. He also says that certain doses of nanoparticles could be toxic, so his team is conducting tests to find the best nanoparticle.


'/>"/>

Contact: Vanessa Wasta
wasta@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nanoscale stealth probe slides into cell walls seamlessly, say Stanford engineers
2. Cochlear Appoints Switched on Media to Develop its SEO Across the Asia Pacific Region
3. Researchers create drug to keep tumor growth switched off
4. BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks
5. Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says
6. Researchers discover brain tumors grow-or-go switch
7. Discovery of cellular switch may provide new means of triggering cell death, treating disease
8. UBC graduate student finds a start/stop switch for retroviruses
9. Brains master switch is verified by Iowa State University researcher
10. Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists
11. Memorys master switch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... has selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation Improvement (CDI) ... ezNLP, and a patent pending ICD-10 solution - ezCAC is an enterprise-level coding ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Castle Dermatology Institute ... practice. Dr. Pedram Ghasri is a graduate of the University of California, Los Angeles. ... his studies at the University of California, Irvine Medical School. As a nationally recognized ...
(Date:8/31/2015)... ... August 31, 2015 , ... “My mother and husband ... inventor, from Hagerhill, Ky. “I thought there could be a comfortable way to prevent ... The Nasal Cannula Ear Protector offers a more secure way to anchor the cannula ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... A year ... the team is preparing to release a new issue commemorating the successful first year. ... information they need for a potentially difficult time in their lives,” says Melissa Wolfert, ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s big news for ... the digital healthcare industry. , Consumer driven health plans (CDHPs) are a growing ... advisory and strategic role to the company, and another to answer customers’ questions directly. ...
Breaking Medicine News(10 mins):Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3
... Mountain View, CA December 5, 2008 ... on developing technologies and products for immune disorders, ... therapeutic treatment for Graft versus Host Disease (GvHD) ... being held December 6 through 9 in San ...
... pseudoephedrine for kids under 2 poses toxicity issues because ... -- Exposure to the decongestant pseudoephedrine, found in many ... among children in the United States. , This is ... the highest risk for toxicity and for whom safe ...
... a USGS study released today,showing that man-made chemicals remained ... the Water Quality Association is encouraging consumers,to educate themselves ... According to a report by the U.S. Geological ... removed by public treatment processes. The,USGS examined water ...
... Launched by Product Stewardship Institute and King Pharmaceuticals ... 5 /PRNewswire-USNewswire/ - - The Product Stewardship ... Dialogue Meeting earlier this week in Washington, DC ... medications to combat increasing rates of prescription drug abuse, ...
... AIDS-causing virus don,t get sick , , FRIDAY, Dec. 5 (HealthDay ... of how a small number of HIV-infected people manage to ... medicine. , The key seems to be an unusual feature ... hope it might lead to better drug therapies or even ...
... another reason to quit smoking, consider that it may diminish ... the University of Rochester Medical Center have found that women ... were significantly more likely to face fertility problems and suffer ... non-smoking women showed those who were exposed to second hand ...
Cached Medicine News:Health News:Decongestant Exposure Needs Closer Look 2Health News:Chemicals Remain in Most Treated Water, Says Report 2Health News:Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications 2Health News:Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications 3Health News:Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications 4Health News:Special Immune Cells May Be Key to HIV Resistance 2Health News:Secondhand smoke raises odds of fertility problems in women 2
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, 2015 /PRNewswire/ ... and the life sciences team at Google announced today ... for people with type 1 and type 2 diabetes. ... with Google,s expertise in analytics, miniaturized electronics and low ... improve diabetes care by developing new tools that bring ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... 15 Omega 3 fatty acids bound to,phospholipids ... natural,alternative and may have beneficial effect on impulsivity ... While several studies have reported,beneficial effects of omega-3 ... have specific positive effects on,impulse control., These ...
... May 14 Biopure Corporation,(Nasdaq: BPUR ... its Phase II coronary,revascularization trial have been ... is entitled "Proof-of-concept trial to,evaluate haemoglobin based ... protocol design, and haemodynamic,results." The manuscript was ...
Cached Medicine Technology:Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 2Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 3
... a two chain (alpha- and beta-subunits) glycoprotein ... the placenta and is normally found in ... the trophoblastic epithelium of the placenta, hCG ... the early stages of pregnancy. The primary ...
... for movement is critical ... wheelchairs. Thats why this ... technology to do just ... state-of-the-art technology, these wheelchair ...
When patients are less mobile our ProPlus™ Stand-On Scale with built-in wheels moves easily to them. Extremely durable and safe, the easy grip handrail and non-skid platform provide added suppo...
... 100 provides a new screening, diagnostic, treatment ... medical management of sleep-related breathing disorders. The ... unmet need for an ambulatory, reliable, patient ... to the great number of OSA sufferers, ...
Medicine Products: